(3R)-6-cyclohexyl-N-hydroxy-3-(5-phenyl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-4-yl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrimidin-5-yl-1,2,4-oxadiazol-3-yl)hexanamide

C96H131N19O15 — CID 161215570

IUPAC(3R)-6-cyclohexyl-N-hydroxy-3-(5-phenyl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-4-yl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrimidin-5-yl-1,2,4-oxadiazol-3-yl)hexanamide
SMILESO=C(C[C@@H](CCCC1CCCCC1)c1ncc(-c2ccccc2)o1)NO.O=C(C[C@@H](CCCC1CCCCC1)c1ncc(-c2ccncc2)o1)NO.O=C(C[C@@H](CCCC1CCCCC1)c1noc(-c2cccnc2)n1)NO.O=C(C[C@@H](CCCC1CCCCC1)c1noc(-c2cnccn2)n1)NO.O=C(C[C@@H](CCCC1CCCCC1)c1noc(-c2cncnc2)n1)NO
InChIInChI=1S/C21H28N2O3.C20H27N3O3.C19H26N4O3.2C18H25N5O3/c24-20(23-25)14-18(13-7-10-16-8-3-1-4-9-16)21-22-15-19(26-21)17-11-5-2-6-12-17;24-19(23-25)13-17(8-4-7-15-5-2-1-3-6-15)20-22-14-18(26-20)16-9-11-21-12-10-16;24-17(22-25)12-15(9-4-8-14-6-2-1-3-7-14)18-21-19(26-23-18)16-10-5-11-20-13-16;24-16(22-25)9-14(8-4-7-13-5-2-1-3-6-13)17-21-18(26-23-17)15-10-19-12-20-11-15;24-16(22-25)11-14(8-4-7-13-5-2-1-3-6-13)17-21-18(26-23-17)15-12-19-9-10-20-15/h2,5-6,11-12,15-16,18,25H,1,3-4,7-10,13-14H2,(H,23,24);9-12,14-15,17,25H,1-8,13H2,(H,23,24);5,10-11,13-15,25H,1-4,6-9,12H2,(H,22,24);10-14,25H,1-9H2,(H,22,24);9-10,12-14,25H,1-8,11H2,(H,22,24)/t18-;17-;15-;2*14-/m11111/s1
InChIKeyUWUUBOBHPSECRJ-AHCTZMOHSA-N
MW1791.22 g/mol
LogP19.91
Rot. Bonds40

About (3R)-6-cyclohexyl-N-hydroxy-3-(5-phenyl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-4-yl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrimidin-5-yl-1,2,4-oxadiazol-3-yl)hexanamide

(3R)-6-cyclohexyl-N-hydroxy-3-(5-phenyl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-4-yl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrimidin-5-yl-1,2,4-oxadiazol-3-yl)hexanamide (PubChem CID 161215570) has the molecular formula C96H131N19O15 and a molecular weight of 1791.22 g/mol. Its IUPAC name is (3R)-6-cyclohexyl-N-hydroxy-3-(5-phenyl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-4-yl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrimidin-5-yl-1,2,4-oxadiazol-3-yl)hexanamide.

Molecular Properties

Compound Name(3R)-6-cyclohexyl-N-hydroxy-3-(5-phenyl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-4-yl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrimidin-5-yl-1,2,4-oxadiazol-3-yl)hexanamide
PubChem CID161215570
Molecular FormulaC96H131N19O15
Molecular Weight1791.22 g/mol
Exact Mass1790.01
IUPAC Name(3R)-6-cyclohexyl-N-hydroxy-3-(5-phenyl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-4-yl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrimidin-5-yl-1,2,4-oxadiazol-3-yl)hexanamide
SMILESO=C(C[C@@H](CCCC1CCCCC1)c1ncc(-c2ccccc2)o1)NO.O=C(C[C@@H](CCCC1CCCCC1)c1ncc(-c2ccncc2)o1)NO.O=C(C[C@@H](CCCC1CCCCC1)c1noc(-c2cccnc2)n1)NO.O=C(C[C@@H](CCCC1CCCCC1)c1noc(-c2cnccn2)n1)NO.O=C(C[C@@H](CCCC1CCCCC1)c1noc(-c2cncnc2)n1)NO
InChIInChI=1S/C21H28N2O3.C20H27N3O3.C19H26N4O3.2C18H25N5O3/c24-20(23-25)14-18(13-7-10-16-8-3-1-4-9-16)21-22-15-19(26-21)17-11-5-2-6-12-17;24-19(23-25)13-17(8-4-7-15-5-2-1-3-6-15)20-22-14-18(26-20)16-9-11-21-12-10-16;24-17(22-25)12-15(9-4-8-14-6-2-1-3-7-14)18-21-19(26-23-18)16-10-5-11-20-13-16;24-16(22-25)9-14(8-4-7-13-5-2-1-3-6-13)17-21-18(26-23-17)15-10-19-12-20-11-15;24-16(22-25)11-14(8-4-7-13-5-2-1-3-6-13)17-21-18(26-23-17)15-12-19-9-10-20-15/h2,5-6,11-12,15-16,18,25H,1,3-4,7-10,13-14H2,(H,23,24);9-12,14-15,17,25H,1-8,13H2,(H,23,24);5,10-11,13-15,25H,1-4,6-9,12H2,(H,22,24);10-14,25H,1-9H2,(H,22,24);9-10,12-14,25H,1-8,11H2,(H,22,24)/t18-;17-;15-;2*14-/m11111/s1
InChIKeyUWUUBOBHPSECRJ-AHCTZMOHSA-N
XLogP19.91
TPSA492.81 Ų
H-Bond Donors10
H-Bond Acceptors29
Rotatable Bonds40
Heavy Atoms130
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001791.22
LogP ≤ 519.91
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1029

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze (3R)-6-cyclohexyl-N-hydroxy-3-(5-phenyl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-4-yl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrimidin-5-yl-1,2,4-oxadiazol-3-yl)hexanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[4-Fluoro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-[2-[[5-(trifluoromethyl)pyrazin-2-yl]methyl]-7-azabicyclo[2.2.1]heptan-7-yl]methanone;[2-fluoro-6-(1,3-oxazol-2-yl)phenyl]-[2-[[5-(trifluoromethyl)pyrazin-2-yl]methyl]-7-azabicyclo[2.2.1]heptan-7-yl]methanone;[5-fluoro-2-(1,3-oxazol-2-yl)phenyl]-[2-[[5-(trifluoromethyl)pyrazin-2-yl]methyl]-7-azabicyclo[2.2.1]heptan-7-yl]methanone
CID 159827910
2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-oxazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-oxazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;platinum;tris(platinum(2+))
CID 157267392
8,8-dimethyl-3-(1-pyridin-2-ylimidazol-4-yl)-7,9-dihydro-6H-pyrido[2,1-b]quinazolin-11-one;8,8-dimethyl-3-(4-pyridin-2-ylimidazol-1-yl)-7,9-dihydro-6H-pyrido[2,1-b]quinazolin-11-one;bis(8,8-dimethyl-3-(5-pyridin-2-yl-1,2-oxazol-3-yl)-7,9-dihydro-6H-pyrido[2,1-b]quinazolin-11-one);8,8-dimethyl-3-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7,9-dihydro-6H-pyrido[2,1-b]quinazolin-11-one
CID 157362711
4-[(5-cyano-1,2,4-oxadiazol-3-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide;4-[(5-cyano-1,3,4-oxadiazol-2-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide;4-(5-cyano-1,2,4-oxadiazol-3-yl)-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide;4-(5-cyano-1,3,4-oxadiazol-2-yl)-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide;4-[(2-cyano-1,3-oxazol-5-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
CID 157444891
N-[3-[(5-methoxypyrimidin-2-yl)amino]propyl]-5-phenyl-1,2-oxazole-3-carboxamide;N-[3-[(5-methyl-2-pyridinyl)amino]propyl]-5-phenyl-1,2-oxazole-3-carboxamide;N-[3-[(2-methylpyrimidin-4-yl)amino]propyl]-5-phenyl-1,2-oxazole-3-carboxamide;N-[3-[(6-methylpyrimidin-4-yl)amino]propyl]-5-phenyl-1,2-oxazole-3-carboxamide;5-phenyl-N-[3-[(2-piperidin-1-ylpyrimidin-4-yl)amino]propyl]-1,2-oxazole-3-carboxamide
CID 157468512
[4-Fluoro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-[6-[(5-methyl-2-pyridinyl)oxy]-2-azabicyclo[2.2.1]heptan-2-yl]methanone;[2-fluoro-6-(1,3-oxazol-2-yl)phenyl]-[6-[(5-methyl-2-pyridinyl)oxy]-2-azabicyclo[2.2.1]heptan-2-yl]methanone;[5-fluoro-2-(1,3-oxazol-2-yl)phenyl]-[6-[(5-methyl-2-pyridinyl)oxy]-2-azabicyclo[2.2.1]heptan-2-yl]methanone;[6-[(5-methyl-2-pyridinyl)oxy]-2-azabicyclo[2.2.1]heptan-2-yl]-(5-methyl-2-pyrimidin-2-yl-3-pyridinyl)methanone
CID 157599094
3-[4-(3,6-diphenylcarbazol-9-yl)-3,5-diphenylphenyl]-[1]benzofuro[2,3-b]pyrazine;2-[4-(3,6-diphenylcarbazol-9-yl)-3,5-diphenylphenyl]-[1]benzofuro[2,3-d]pyrimidine;2-[4-(3,6-diphenylcarbazol-9-yl)-3,5-diphenylphenyl]-[1]benzofuro[3,2-d]pyrimidine;4-[4-(3,6-diphenylcarbazol-9-yl)-3,5-diphenylphenyl]-[1]benzofuro[2,3-d]pyrimidine;2-[4-(3,6-diphenylcarbazol-9-yl)-3,5-diphenylphenyl]-4-[(1E,3Z)-hexa-1,3,5-trienyl]-[1]benzofuro[3,2-d]pyrimidine;4-[4-(3,6-diphenylcarbazol-9-yl)-3,5-diphenylphenyl]-2-phenyl-[1]benzofuro[2,3-d]pyrimidine;2-[4-(3,6-diphenylcarbazol-9-yl)-3,5-diphenylphenyl]-3-phenyl-[1]benzofuro[3,2-d]pyrimidin-3-ium;3-[4-(3,6-diphenylcarbazol-9-yl)-3-[(3E)-hexa-1,3,5-trien-3-yl]-5-phenylphenyl]-2-phenyl-[1]benzofuro[2,3-b]pyrazine
CID 157627739
3-Benzyl-5-(2,2-dimethylpropyl)-1,2,4-oxadiazole;5-cyclopropyl-3-(2,2-dimethylpropyl)-1,2,4-oxadiazole;2-(3,3-dimethylbutyl)-6-methylpyridine;bis(2-(3,3-dimethylbutyl)pyridine);2-(3,3-dimethylbutyl)pyrimidine;2-(2,2-dimethylpropyl)-4,5-dimethyl-1,3-oxazole;2-(2,2-dimethylpropyl)-4-methylfuran;2-(2,2-dimethylpropyl)-4-methyl-1,3-oxazole;2-(2,2-dimethylpropyl)-5-methyl-1,3-oxazole;3-(2,2-dimethylpropyl)-5-methyl-1,2-oxazole;5-(2,2-dimethylpropyl)-2-methyl-1,3-oxazole;5-(2,2-dimethylpropyl)-3-methyl-1,2-oxazole;5-(2,2-dimethylpropyl)-3-phenyl-1,2-oxazole;2-(2,2-dimethylpropyl)pyridine;bis(2-(2,2-dimethylpropyl)pyrimidine)
CID 157879531
N-[3-[(2-hydroxyphenyl)methylamino]propyl]-5-phenyl-1,2-oxazole-3-carboxamide;N-[3-[(5-methoxypyrimidin-2-yl)amino]propyl]-5-phenyl-1,2-oxazole-3-carboxamide;N-[3-[(2-methylpyrimidin-4-yl)amino]propyl]-5-phenyl-1,2-oxazole-3-carboxamide;N-[3-[(6-methylpyrimidin-4-yl)amino]propyl]-5-phenyl-1,2-oxazole-3-carboxamide;5-phenyl-N-[3-[(2-piperidin-1-ylpyrimidin-4-yl)amino]propyl]-1,2-oxazole-3-carboxamide
CID 158083349
8,8-dimethyl-3-(4-pyridin-2-ylimidazol-1-yl)-7,9-dihydro-6H-pyrido[2,1-b]quinazolin-11-one;bis(8,8-dimethyl-3-(5-pyridin-2-yl-1,2-oxazol-3-yl)-7,9-dihydro-6H-pyrido[2,1-b]quinazolin-11-one);bis(8,8-dimethyl-3-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7,9-dihydro-6H-pyrido[2,1-b]quinazolin-11-one)
CID 158194161
2-[2-[3-(1,3-Benzoxazol-2-yl)-2-pyridinyl]-3-pyridinyl]-1,3-benzoxazole;2-[5-[5-(1,3-benzoxazol-2-yl)-3-pyridinyl]-3-pyridinyl]-1,3-benzoxazole;1-phenyl-2-[2-[3-(1-phenylbenzimidazol-2-yl)-2-pyridinyl]-3-pyridinyl]benzimidazole;1-phenyl-2-[5-[5-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]benzimidazole;2-propan-2-yl-1,3-benzoxazole
CID 158210118
2-phenyl-3-propan-2-ylpyridine;2-phenyl-5-propan-2-ylpyridine;2-phenyl-6-propan-2-ylpyridine;3-phenyl-2-propan-2-ylpyridine;3-phenyl-5-propan-2-ylpyridine;4-phenyl-2-propan-2-ylpyridine;4-phenyl-3-propan-2-ylpyridine;5-phenyl-2-propan-2-ylpyridine;6-propan-2-ylfuro[2,3-b]pyridine;6-propan-2-ylfuro[3,2-b]pyridine;5-propan-2-yl-1H-imidazo[4,5-b]pyridine;6-propan-2-yl-1H-imidazo[4,5-b]pyridine;5-propan-2-yl-[1,3]oxazolo[5,4-b]pyridine;6-propan-2-yl-[1,3]oxazolo[4,5-b]pyridine;6-propan-2-yl-1H-pyrrolo[2,3-b]pyridine;6-propan-2-yl-1H-pyrrolo[3,2-b]pyridine
CID 158232279

Frequently Asked Questions

What is the IUPAC name of (3R)-6-cyclohexyl-N-hydroxy-3-(5-phenyl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-4-yl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrimidin-5-yl-1,2,4-oxadiazol-3-yl)hexanamide?
The IUPAC name of (3R)-6-cyclohexyl-N-hydroxy-3-(5-phenyl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-4-yl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrimidin-5-yl-1,2,4-oxadiazol-3-yl)hexanamide (CID 161215570) is (3R)-6-cyclohexyl-N-hydroxy-3-(5-phenyl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-4-yl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrimidin-5-yl-1,2,4-oxadiazol-3-yl)hexanamide.
What is the SMILES notation for (3R)-6-cyclohexyl-N-hydroxy-3-(5-phenyl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-4-yl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrimidin-5-yl-1,2,4-oxadiazol-3-yl)hexanamide?
The canonical SMILES for (3R)-6-cyclohexyl-N-hydroxy-3-(5-phenyl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-4-yl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrimidin-5-yl-1,2,4-oxadiazol-3-yl)hexanamide is O=C(C[C@@H](CCCC1CCCCC1)c1ncc(-c2ccccc2)o1)NO.O=C(C[C@@H](CCCC1CCCCC1)c1ncc(-c2ccncc2)o1)NO.O=C(C[C@@H](CCCC1CCCCC1)c1noc(-c2cccnc2)n1)NO.O=C(C[C@@H](CCCC1CCCCC1)c1noc(-c2cnccn2)n1)NO.O=C(C[C@@H](CCCC1CCCCC1)c1noc(-c2cncnc2)n1)NO.
What is the InChIKey of (3R)-6-cyclohexyl-N-hydroxy-3-(5-phenyl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-4-yl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrimidin-5-yl-1,2,4-oxadiazol-3-yl)hexanamide?
The InChIKey is UWUUBOBHPSECRJ-AHCTZMOHSA-N. The full InChI is InChI=1S/C21H28N2O3.C20H27N3O3.C19H26N4O3.2C18H25N5O3/c24-20(23-25)14-18(13-7-10-16-8-3-1-4-9-16)21-22-15-19(26-21)17-11-5-2-6-12-17;24-19(23-25)13-17(8-4-7-15-5-2-1-3-6-15)20-22-14-18(26-20)16-9-11-21-12-10-16;24-17(22-25)12-15(9-4-8-14-6-2-1-3-7-14)18-21-19(26-23-18)16-10-5-11-20-13-16;24-16(22-25)9-14(8-4-7-13-5-2-1-3-6-13)17-21-18(26-23-17)15-10-19-12-20-11-15;24-16(22-25)11-14(8-4-7-13-5-2-1-3-6-13)17-21-18(26-23-17)15-12-19-9-10-20-15/h2,5-6,11-12,15-16,18,25H,1,3-4,7-10,13-14H2,(H,23,24);9-12,14-15,17,25H,1-8,13H2,(H,23,24);5,10-11,13-15,25H,1-4,6-9,12H2,(H,22,24);10-14,25H,1-9H2,(H,22,24);9-10,12-14,25H,1-8,11H2,(H,22,24)/t18-;17-;15-;2*14-/m11111/s1.
What are the key properties of (3R)-6-cyclohexyl-N-hydroxy-3-(5-phenyl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-4-yl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrimidin-5-yl-1,2,4-oxadiazol-3-yl)hexanamide?
(3R)-6-cyclohexyl-N-hydroxy-3-(5-phenyl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-4-yl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrimidin-5-yl-1,2,4-oxadiazol-3-yl)hexanamide has a molecular weight of 1791.22 g/mol, XLogP of 19.91, 40 rotatable bonds, 10 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for (3R)-6-cyclohexyl-N-hydroxy-3-(5-phenyl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyridin-4-yl-1,3-oxazol-2-yl)hexanamide;(3R)-6-cyclohexyl-N-hydroxy-3-(5-pyrimidin-5-yl-1,2,4-oxadiazol-3-yl)hexanamide is sourced from PubChem (CID 161215570), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).